Endoxifen Levels Associated to CYP2D6 Phenotype

被引：0
|
作者：
Antunes, M., V [1 ]
Santos, T., V [1 ]
Andreolla, H. [1 ]
Rosa, D. D. [1 ]
Linden, R. [1 ]
机构：
[1] Univ Feevale, Novo Hamburgo, RS, Brazil
来源：
THERAPEUTIC DRUG MONITORING | 2013年 / 35卷 / 05期
关键词：
CYP2D6; endoxifen; tamoxifen; phenotyping;
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：710 / 710
页数：1
相关论文
共 50 条
  • [1] Correlation of endoxifen pharmacokinetics and CYP2D6 genotypes
    Tchu, S. M.
    Wang, P.
    Stone, J.
    Ziv, E.
    Lorizio, W.
    Wu, A.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A167 - A167
  • [2] Bupropion plasma levels and CYP2D6 phenotype
    Pollock, BG
    Sweet, RA
    Kirshner, M
    Reynolds, CF
    THERAPEUTIC DRUG MONITORING, 1996, 18 (05) : 581 - 585
  • [3] CYP2D6 and CYP3A influence tamoxifen and endoxifen
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (05) : 524 - 525
  • [4] Is CYP2D6 phenotype predictable from CYP2D6 genotype?
    Kiss, Adam Ferenc
    Toth, Katalin
    Juhasz, Cintia
    Temesvari, Manna
    Paulik, Jozsef
    Hirka, Gabor
    Monostory, Katalin
    MICROCHEMICAL JOURNAL, 2018, 136 : 209 - 214
  • [5] Endoxifen Levels and Its Association With CYP2D6 Genotype and Phenotype: Evaluation of a Southern Brazilian Population Under Tamoxifen Pharmacotherapy
    Antunes, Marina V.
    Linden, Rafael
    Santos, Tamyris V.
    Wallemacq, Pierre
    Haufroid, Vincent
    Classen, Jean-Francois
    Andreolla, Huander
    Costa, Nathalia
    Fontanive, Tiago O.
    Rosa, Daniela D.
    THERAPEUTIC DRUG MONITORING, 2012, 34 (04) : 422 - 431
  • [6] Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors
    Gressier, F.
    Verstuyft, C.
    Hardy, P.
    Becquemont, L.
    Corruble, E.
    JOURNAL OF NEURAL TRANSMISSION, 2015, 122 (01) : 35 - 42
  • [7] CONCORDANCE OF PHENOTYPE AND GENOTYPE FOR CYP2D6
    MCLEOD, HL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 56 (04) : 463 - 463
  • [8] Response to CYP2D6 substrate antidepressants is predicted by a CYP2D6 composite phenotype based on genotype and comedications with CYP2D6 inhibitors
    F. Gressier
    C. Verstuyft
    P. Hardy
    L. Becquemont
    E. Corruble
    Journal of Neural Transmission, 2015, 122 : 35 - 42
  • [9] SIMPLIFIED CYP2D6 METABOLIZER PHENOTYPE CATEGORIZATION OF PATIENTS TREATED WITH TAMOXIFEN: ROLE FOR ENDOXIFEN LEVEL MONITORING?
    Lee, C. L.
    Low, A. S. K.
    Fox, P.
    Balakrishnar, B.
    Balleine, R. L.
    Gao, B.
    Provan, P.
    Coulter, S.
    Liddle, C.
    Hui, R.
    Wilcken, N.
    Wong, M.
    Gurney, H.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 59 - 59
  • [10] Optimized CYP2D6 phenotype assignment for plasma endoxifen prediction in breast cancer patients treated with tamoxifen
    Schroth, Werner
    Winter, Stefan
    Eichelbaum, Michel
    Muerdter, Thomas
    Schwab, Matthias
    Brauch, Hiltrud
    CANCER RESEARCH, 2017, 77
12345